“A STABILITY-INDICATING HPLC METHOD FOR THE DETERMINATION OF POTENTIAL IMPURITIES IN A NEW FIXED DOSE COMBINATION OF DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS USED IN THE FIRST LINE TREATMENT OF HIV-1 INFECTION”. International Research Journal of Pharmacy, vol. 9, no. 5, May 2018, pp. 90-99, https://irjponline.org/index.php/irjp/article/view/1071.